An in-depth analysis of the mechanism of the L-type Ca 2ϩ current [I Ca(L) ] stimulation induced by myricetin was performed in rat tail artery myocytes using the whole-cell patch-clamp method. Myricetin increased I Ca(L) in a frequency-, concentration-, and voltage-dependent manner. At holding potentials (V h ) of Ϫ50 and Ϫ90 mV, the pEC 50 values were 4.9 Ϯ 0.1 and 4.2 Ϯ 0.1, respectively; the latter corresponded to the drug-apparent dissociation constant for resting channels, K R , of 67.6 M. Myricetin shifted the maximum of the current-voltage relationship by 10 mV in the hyperpolarizing direction but did not modify the threshold for I Ca(L) or the T-type Ca 2ϩ current. The Ca 2ϩ channel blockers nifedipine, verapamil, and diltiazem antagonized I Ca(L) in the presence of myricetin. Myricetin increased the time to peak of I Ca(L) in a voltage-and concentration-dependent manner. Washout reverted myricetin effect on both current kinetics and amplitude at V h of Ϫ90 mV while reverting only current kinetics at V h of Ϫ50 mV. At the latter V h , myricetin shifted the voltage dependence of inactivation and activation curves to more negative potentials by 6.4 and 13.0 mV, respectively, in the mid-potential of the curves. At V h of Ϫ90 mV, myricetin shifted, in a concentration-dependent manner, the voltage dependence of the inactivation curve to more negative potentials with an apparent dissociation constant for inactivated channels (K I ) of 13.8 M. Myricetin induced a frequency-and V h -dependent block of I Ca(L) . In conclusion, myricetin behaves as an L-type Ca 2ϩ channel agonist that stabilizes the channel in its inactivated state.
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Food provides not only essential nutrients but also other bioactive compounds (e.g., flavonoids) good for health promotion and disease prevention (Middleton et al., 2000; World Health Organization, 2002) . Regular consumption of fruit and vegetables, for example, is associated with a reduced risk of cancer, cardiovascular disease, stroke, Alzheimer's disease, cataract, and some of the functional declines associated with aging (Liu, 2003) .
Red wine extracts, which are very rich in flavonoids, in bovine aortic endothelial cells, strongly inhibit the synthesis of endothelin-1 (Corder et al., 2001 ), a vasoactive peptide that is linked to the development of coronary arteriosclerosis. Oral administration of red wine polyphenolic compounds has recently been shown to produce antihypertensive effects in both spontaneously hypertensive (Duarte et al., 2001 ) and deoxycorticosterone acetate-salt-hypertensive rats (Galisteo et al., 2004a,b) , as well as to decrease blood pressure in normotensive rats (Diebolt et al., 2001 ). In addition, red wine polyphenols increase nitric oxide production in rat aorta (Benito et al., 2002) via the intracellular Ca 2ϩ increase in endothelial cells and activation of tyrosine kinases (Martin et al., 2002) . These findings help to explain the French paradox (Renaud and de Lorgeril, 1992) and the relationship between the Mediterranean diet based primarily on flavonoid-rich foods (Allium, Petroselinum, and Brassica vegetables and red wine) and the increased longevity (Orgogozo et al., 1997) , accompanied by a low incidence of cardiovascular diseases, in Mediterranean populations (Hertog et al., 1995) .
The beneficial effect of flavonoids on human health, although highlighted in some prospective epidemiological studies, is not fully established (Hertog et al., 1997) . Dietary flavonoids are found in human plasma in sub-micromolar or micromolar concentrations, either as aglycon or as glucosilate/glycosilate metabolites (Paganga and Rice-Evans, 1997; Erlund et al., 2000; Scalbert and Williamson, 2000; Graefe et al., 2001) , and some studies have clarified the molecular mechanisms of their effects on vascular tissues. Quercetin (3,3Ј,4Ј,5,7-pentahydroxyflavone), although inducing both endothelium-dependent (Fusi et al., 2003b) and endotheliumindependent vasorelaxation in vitro (Duarte et al., 1993; Herrera et al., 1996) , has been demonstrated to be an effec-tive stimulator of vascular smooth muscle L-type Ca 2ϩ channels . This effect, however, is paradoxically accompanied by vasorelaxation, which presumably takes place via pathways [e.g., protein kinase C inhibition (see Duarte et al., 1993) , among others] more prominent than L-type channel-mediated Ca 2ϩ influx in the hierarchy of functional competences (Fusi et al., 2003b) . Myricetin (3, 3Ј, 4Ј, 5, 5Ј, (Fig. 1a) was recently shown to increase I Ca(L) in rat tail artery myocytes and cause contraction in 20 mM KCl-depolarized rat aorta rings without interacting with the dihydropyridine binding site (Fusi et al., 2003a ). The present study provides an in-depth analysis of the L-type Ca 2ϩ channel stimulation performed by myricetin on isolated rat tail artery myocytes.
Materials and Methods
Cell Isolation Procedure. This study has been carried out in accordance with the Declaration of Helsinki and/or with the Guide for the Care and Use of Laboratory Animals as adopted and promulgated by the U.S. National Institutes of Health. Male SpragueDawley rats (350 -450 g; Charles River Italia, Calco, Italy) were anesthetized with a mixture of Ketavet (Gellini, Italy) and Rompum (Bayer, AG, Wuppertal, Germany), decapitated, and bled. Smooth muscle cells, freshly isolated from the tail main artery by means of collagenase treatment in the presence of bovine serum albumin and trypsin inhibitor as previously described , exhibited an ellipsoid form (10 -15 m in width, 35-55 m in length). The cells were continuously superfused with external solution containing 0.1 mM Ca 2ϩ (PSS; see below for composition) by using an LKB 2132 peristaltic pump at a flow rate of 500 l min Ϫ1 . At the end of each experiment, both the perfusion system and bath were thoroughly rinsed once with ethanol and several times with water as well as daily with H 2 O 2 to avoid contamination of any source. Electrophysiological responses were tested at room temperature (22-24°C) only in those cells that were phase-dense. Cell membrane capacitance averaged 47.9 Ϯ 1.2 pF (n ϭ 71). The time constant of the voltageclamp averaged 0.7 Ϯ 0.1 ms (n ϭ 71).
Whole-Cell Patch Clamp Recording. Conventional (Hamill et al., 1981) whole-cell patch-clamp method was employed to voltageclamp smooth muscle cells. Recording electrodes were pulled from borosilicate glass capillaries (WPI, Berlin, Germany) and fire-polished to obtain a pipette resistance of 2 to 5 M⍀ when filled with internal solution. A low-noise, high-performance Axopatch 200B (Axon Instruments Inc., Union City, CA) patch-clamp amplifier, driven by an IBM computer in conjunction with an A/D, D/A board (DigiData 1200 A/B series interface; Axon Instruments Inc.), was used to generate and apply voltage pulses to the clamped cells and record the corresponding membrane currents. Current signals, after compensation for whole-cell capacitance, series resistance, and liquid junction potential, were low-pass filtered at 1 kHz and digitized at 3 kHz prior to being stored on the computer hard disk. I Ca was always recorded in 5 mM Ca 2ϩ -containing PSS; this concentration was shown to cause maximal peak current in arterial smooth muscle cells (Bolton et al., 1988) . I Ca was measured over a range of test potentials of 250-ms duration from Ϫ50 to 70 mV from a holding potential (V h ) of Ϫ50 or Ϫ90 mV. Data were collected once the current amplitude had been stabilized (usually 7-10 min after the whole-cell configuration had been obtained). I Ca did not run down during the following 30 to 40 min under these conditions. To study the effect of some L-type Ca 2ϩ channel antagonists (nifedipine, diltiazem, and verapamil) on I Ca(L) recorded in the presence of myricetin, myocytes were preincubated with the flavonoid, and after a stable response had been attained, cumulative concentrations of the antagonists were added to the bath solution.
A two-pulse protocol was applied to record T-type Ca 2ϩ currents [I Ca(T) ], avoiding overlap of I Ca(L) . The cell was first depolarized for a 250-ms period to Ϫ40 mV from V h of Ϫ90 mV to elicit I Ca(T) . Following a 6-s return to the initial V h , a 250-ms clamp pulse to 10 mV was applied to record I Ca(L) , which was taken as 100%.
Steady-state inactivation curves, recorded twice from the same cell (in the absence and presence of the drug, respectively), were obtained using a double-pulse protocol (Rubart et al., 1996) . Once various levels of the conditioning potential had been applied for 5 s, followed by a short (5-ms) return to the V h , a test pulse (250 ms) to 0 mV was delivered to evoke the current. Under control conditions, the 50% inactivation potential, evaluated by fitting a Boltzmann distribution to the first curve, was not significantly different from that of the second curve recorded after 10 min .
Activation curves were derived from the current-voltage relationships (see Fig. 2c ). Conductance (G) was calculated from the equation G ϭ I Ca /(E m ϪE Ca ), where I Ca is the peak current elicited by depolarizing test pulses from Ϫ50 to 30 mV from V h of Ϫ50 mV, E m is the membrane potential, and E Ca is the equilibrium potential for Ca 2ϩ (181 mV, as estimated with the Nernst equation). G max is the maximal Ca 2ϩ conductance (calculated at potentials Ն10 mV). The ratio G/G max was plotted against the membrane potential and fitted with the Boltzmann equation. K ϩ currents were blocked with 30 mM tetraethylammonium chloride in the PSS and Cs ϩ in the internal solution (see below). Current values were corrected for leakage using 300 M Cd 2ϩ , which was assumed to completely block I Ca .
Solutions and Chemicals. PSS contained 130 mM NaCl, 5.6 mM KCl, 10 mM HEPES, 20 mM glucose, 1.2 mM MgCl 2 , 5 mM sodium pyruvate, and 0.1 or 5 mM CaCl 2 (pH 7.4). The internal solution for the conventional whole-cell method (pCa 8.4) consisted of 105 mM CsCl, 10 mM HEPES, 11 mM EGTA, 2 mM MgCl 2 , 1 mM CaCl 2 , 5 mM sodium pyruvate, 5 mM succinic acid, 5 mM oxalacetic acid, 3 mM Na 2 ATP, and 5 mM phosphocreatine; pH was adjusted to 7.4 with CsOH. The osmolarity of PSS (320 mOsmol) and that of the internal solution (290 mOsmol) (Stansfeld and Mathie, 1993) were measured with an Osmostat OM 6020 osmometer (Menarini Diagnostics, Florence, Italy).
The chemicals used were collagenase (type XI), tetraethylammonium chloride, bovine serum albumin, trypsin inhibitor, nifedipine, diltiazem, verapamil, CdCl 2 , and myricetin (Sigma-Aldrich, Milan, Italy). Myricetin dissolved directly in dimethylsulphoxide and nifedipine dissolved in ethanol were diluted at least 1000 times in PSS prior to use. The resulting concentrations of dimethylsulphoxide and ethanol (below 0.1%) failed to alter the current (data not shown). Final drug concentrations are reported in the text. Unless otherwise stated, 20 M myricetin was always used. Following control measurements, each cell was exposed to a drug by flushing through the experimental chamber PSS containing that drug.
Statistical Analysis. Acquisition and analysis of data were accomplished by using pClamp 8.2.0.232 software (Axon Instruments Inc.) and GraphPad Prism version 3.03 (GraphPad Software Inc., San Diego, CA). Data are reported as mean Ϯ S.E.M.; n is the number of cells analyzed (indicated in parentheses), isolated from at least three animals. Statistical analyses and significance as mea- sured by either analysis of variance (followed by Dunnett's post test) or Student's t test for unpaired and paired samples (two-tail) were obtained using GraphPad InStat version 3.05 (GraphPad Software Inc.). In all comparisons, p Ͻ 0.05 was considered significant. The current-voltage relationships were calculated on the basis of the peak values (leakage corrected) from the original currents. I Ca(L) activation was analyzed by measuring the time to peak current or the activation time constant (). The pharmacological response to myricetin, described in terms of pEC 50 (the negative logarithm to base 10 of the molar EC 50 ), was evaluated by global nonlinear regression (Motulsky and Christopoulolos, 2003) , assuming that the drug did not affect the maximum of the concentration-response curve in cells clamped at V h of Ϫ90 mV (Fig. 2a) . The apparent dissociation constant for resting channels (K R ) was determined by holding the cells at Ϫ90 mV and measuring the corresponding concentration-response relationship for myricetin at 0.033 Hz. In fact, the number of channels in the resting state can be assayed by the I Ca(L) elicited by a large depolarization from hyperpolarized V h (Bean, 1984) , such as Ϫ90 mV, where the entire population of L-type Ca 2ϩ channels in rat tail artery myocytes is in the resting state (see "Effects of Myricetin on Steady-State Inactivation and Activation Curves for I Ca(L) "), ready to open in response to depolarization. Figure 2a (inset) shows a typical recording of I Ca(L) elicited with a clamp pulse to 0 mV from V h of Ϫ90 mV under control conditions and after the addition of 100 M myricetin. Myricetin enhanced I Ca(L) in a concentration-dependent manner ( Fig. 2a) with an estimated pEC 50 of 4.2 Ϯ 0.1 (n ϭ 3-6) that corresponded to a K R of 67.6 M. Myricetin enhanced I Ca(L) with a potency that depended upon V h . In fact, when V h was held at Ϫ50 mV, the concentration-dependent curve was shifted to the left (pEC 50 of 4.9 Ϯ 0.1, n ϭ 3-6; p Ͻ 0.001, Student's t test for unpaired samples). Figure 2b shows the time course of the effects of myricetin on the current recorded at 0.033 Hz from V h of either Ϫ50 or Ϫ90 mV to a test potential of 0 mV. After I Ca(L) had reached steady values, the addition to bath solution of myricetin produced a gradual increase of the current that reached a plateau in about 3 min at all myricetin concentrations used (data not shown). Noticeably, myricetin-induced stimulation of I Ca(L) was only partially reversible upon drug washout at V h of Ϫ50 mV but completely reversible at V h of Ϫ90 mV. At 2 Hz, under control conditions, the peak amplitude of I Ca(L) decreased rapidly to a steady-state value of about 70% of that recorded during the first pulse (data not shown). The addition of myricetin just after the first pulse of the second train of pulses caused a similar decrease in peak amplitude of I Ca(L) followed by a partial recovery to a steady-state value of about 83% of that recorded during the first pulse (data not shown).
Results

Effects of Myricetin on I Ca(L) and I Ca(T) .
The current-voltage relationship in the conventional whole-cell configuration (Fig. 3) shows that myricetin significantly increased the peak inward current in the range between Ϫ30 and 10 mV and shifted the apparent maximum by 10 mV in the hyperpolarizing direction without, however, varying the threshold at about Ϫ30 mV.
Myocytes used herein express both T-and L-type Ca 2ϩ channels (see Petkov et al., 2001 ). I Ca recorded at Ϫ40 mV from V h of Ϫ90 mV was taken as an indicator of I Ca(T) . This current, in fact, was no longer evident when V h was Ϫ50 mV (data not shown). As shown in Fig. 4 , b and c, myricetin still increased I Ca(L) at 10 mV, although with a lower efficacy compared with V h of Ϫ50 mV (see Fig. 3c ). On the contrary, I Ca(T) was not significantly modified by myricetin (Fig. 4 , a and c), even at a concentration of 100 M (data not shown).
Inhibition by Some L-Type Ca 2؉ Channel Blockers of I Ca(L) Recorded in the Presence of Myricetin. The antagonistic effects of nifedipine, diltiazem, and verapamil were determined after a stable response to myricetin at V h of Ϫ50 mV was attained. All three Ca 2ϩ channel blockers antagonized in a concentration-dependent manner and fully blocked I Ca(L) recorded in the presence of myricetin (Fig. 5) , showing pIC 50 values of 8.0 Ϯ 0.2 (nifedipine, n ϭ 5), 5.7 Ϯ 0.1 (diltiazem, n ϭ 5), and 6.0 Ϯ 0.1 (verapamil, n ϭ 5), respectively. 
Downloaded from
Effects of Myricetin on I Ca(L) Kinetics. The current evoked at 0 mV from V h of either Ϫ50 or Ϫ90 mV activated and then declined with a time course that could be fitted by a monoexponential equation, with a of activation of 3.0 Ϯ 0.3 and 2.02 Ϯ 0.1 ms and a of inactivation of 109.9 Ϯ 9.5 (n ϭ 5) and 85.9 Ϯ 4.2 ms (n ϭ 6), respectively. In the presence of myricetin, activation was delayed, and its time course could be fitted by a biexponential equation at V h of Ϫ50 mV ( 1 ϭ 3.4 Ϯ 0.6 and 2 ϭ 18.9 Ϯ 2.9 ms) and by a monoexponential equation at V h of Ϫ90 mV ( ϭ 3.6 Ϯ 0.5 ms; p Ͻ 0.01, Student's t test for paired samples), respectively. This delay in activation, however, markedly reduced the length of the inactivating segment of traces at V h of Ϫ50 mV, thus impeding its fitting; that at V h of Ϫ90 mV increased to 199.3 Ϯ 10.7 ms (p Ͻ 0.01). The effect of myricetin on the current kinetics was reversible upon washout, and both of activation and of inactivation returned to control values (3.0 Ϯ 0.4 and 114.2 Ϯ 14.6 ms at V h of Ϫ50 mV, and 2.6 Ϯ 0.2 and 96.4 Ϯ 10.3 ms at V h of Ϫ90 mV, respectively). Myricetin prolonged the time to peak of I Ca(L) in a voltage- (Fig. 6a) and concentration-dependent manner (Fig. 6b) , the latter showing a bell-shaped pattern. 
Effects of Myricetin on Steady-State Inactivation and Activation Curves for I Ca(L) .
The voltage dependence of myricetin stimulation was assessed by determining the steady-state inactivation and activation curves for I Ca(L) . At V h of Ϫ50 mV, myricetin significantly shifted the steadystate inactivation curve to more negative potentials (Fig. 7a) . The 50% inactivation potentials, evaluated by means of the Boltzmann fitting procedure, were Ϫ24.2 Ϯ 1.9 (control) and Ϫ30.7 Ϯ 1.5 mV (myricetin; n ϭ 5; p Ͻ 0.01, Student's t test for paired samples), respectively. Furthermore, the slope was significantly steeper in the presence of myricetin (slope factor ϭ Ϫ8.1 Ϯ 0.7 mV, control and Ϫ6.4 Ϯ 0.7 mV, myricetin; p Ͻ 0.05).
The activation curves calculated from the current-voltage relationships in Fig. 3c were fitted with the Boltzmann equation (Fig. 7a) . Myricetin reduced both the 50% activation potential from Ϫ2.5 Ϯ 0.7 to Ϫ13.6 Ϯ 0.6 mV (n ϭ 5; p Ͻ 0.001, Student's t test for paired samples) and the slope factor from 6.6 Ϯ 0.1 mV to 6.1 Ϯ 0.2 mV (p Ͼ 0.05).
The apparent dissociation constant of myricetin for inactivated channels (K I ) was determined by the shift of Ca 2ϩ channel steady-state availability as a function of myricetin concentration at V h of Ϫ90 mV (Bean et al., 1983) . Myricetin shifted the 50% inactivation potential to more hyperpolarizing values in a concentration-dependent manner (Fig. 7b) ; however, it did not modify the slope factors (Ϫ6.7 Ϯ 0.3 mV, control, n ϭ 11; Ϫ6.3 Ϯ 0.6 mV, 3 M myricetin, n ϭ 3; Ϫ5.9 Ϯ 0.4 mV, 10 M myricetin, n ϭ 3; Ϫ6.7 Ϯ 0.1 mV, 20 M myricetin, n ϭ 3; Ϫ6.4 Ϯ 0.2 mV, 100 M myricetin, n ϭ 4). K I was estimated by plotting the 50% inactivation potentials as a function of myricetin concentration. This relationship fitted the equation
where V 50 control and K control were the values of the 50% inactivation potential and the slope measured in control conditions, respectively. The value of K I thus determined was 13.8 Ϯ 2.7 M. The frequency dependence of myricetin-induced effects on I Ca(L) was assessed, as shown in Fig. 8 . In the absence of myricetin, 20 depolarizing pulses of 50-ms duration to 0 mV from V h of Ϫ50 mV were applied at different pulse intervals, ranging from 0.5 to 2 s (2, 1, and 0.5 Hz) (Fig. 8a) . At the end of the protocol, myricetin was added to the bath solution, and after a 4-min interval without stimulation, the same protocol was repeated. In control conditions, the peak amplitude of I Ca(L) evoked by the 20th pulse decreased significantly as the frequency of stimulation increased (Fig. 8b, inset) , thus suggesting a cumulative channel inactivation. Externally applied myricetin produced a frequency-dependent block of I Ca(L) , the highest frequency causing the greatest inhibition. The frequency-dependent block, calculated by normalizing the current amplitude evoked by the 20th applied stimulus against that induced by the first step-pulse, was significantly lower than that observed under the corresponding control conditions only at 2 Hz (Fig. 8b, inset) . Similar results were obtained in parallel experiments wherein Ba 2ϩ was substituted for Ca 2ϩ as charge carrier (data not shown). The frequency-dependent block of I Ca(L) by myricetin depended upon V h (Fig. 8b) . In fact, the residual current recorded at the 20th applied stimulus (2 Hz) from V h of Ϫ50 mV was 57.9 Ϯ 3.4% (n ϭ 3), whereas that from V h of Ϫ90 mV was 91.8 Ϯ 1.2% (n ϭ 3, p Ͻ 0.001, Student's t test for unpaired samples) (Fig. 8b, inset) .
Discussion
The present study provides an in-depth analysis of myricetin-induced stimulation of vascular smooth muscle L-type Ca 2ϩ channels. This flavonoid acted on L-type, but not T-type Ca 2ϩ channels, in a voltage-, concentration-, and frequencydependent manner. A characteristic of myricetin-induced enhancement of I Ca(L) was a marked tonic effect, which developed independently of channel activation. In fact, at 0.033 Hz, a frequency allowing full recovery of rat tail artery myocytes Ca 2ϩ channels from inactivation , the amplitude of I Ca(L) was increased by myricetin in a way that also depended on V h . Furthermore, the amplitude of the first I Ca(L) , recorded after a 4-min silent interval subsequent to myricetin addition, increased to a value identical to that obtained gradually in cells stimulated at a frequency of 0.033 Hz for 4 min in the presence of myricetin. This suggests that myricetin does not need an open channel to have access to its putative binding site and display its stimulatory activity (tonic stimulation).
Myricetin induced a peak current enhancement that reached maximum values at weak depolarization conditions, becoming progressively smaller by increasing membrane depolarization, and shifted the maximum of the current-voltage relationship toward more negative potentials without affecting the threshold for I Ca(L) . Thus, the effect of myricetin on the current-voltage relationship might be explained, at least in part, by the activation curve shift toward more hyperpolarizing potentials, which was more pronounced than that observed in the inactivation curve. In addition, myricetin caused a significant change in the slope of the inactivation curve. These results indicate that myricetin may alter the voltage sensitivity of the channel inactivation mechanism. Furthermore, myricetin strongly slowed Ca 2ϩ channel activation kinetics in a concentration-dependent manner as well as over a wide range of membrane potentials, although this effect was more pronounced at weak depolarization values. The fact that myricetin slowed the time course of current activation while also shifting the steady-state activation curve to more negative potentials can be explained assuming that the flavonoid, in addition to affecting the voltage dependence of the channels, also interferes with Ca 2ϩ -channel gating kinetics, slowing (i.e., increasing the rate constants of) the transition from the closed to the open state of the channel. In other ways, it modifies the gating mechanisms. These observations demonstrate that the two effects depend on myricetin occupancy of binding sites at least partly distinct. A similar phenomenon has been recently described for a series of divalent cations (Castelli et al., 2003) . Finally, the inward tail currents decayed more slowly in the presence of myricetin (data not shown), possibly as a consequence of the longer-lasting opening of the channel.
Together, all these elements indicate that myricetin shares L) by myricetin in rat tail artery myocytes. Tonic and frequency dependence of myricetin-induced effects were examined in the range 0.5 to 2 Hz. In the absence of myricetin, 20 depolarizing 50-ms clamp pulses to 0 mV from V h of either Ϫ50 mV (a) or Ϫ90 mV (b) were applied at 0.5, 1, or 2 Hz, respectively. Myricetin was added just after the delivery of the first train of pulses, and after a 4-min pause, the same protocol was repeated. The peak amplitude elicited by the first pulse at each frequency in the absence of myricetin was taken as 100%. Inset, peak amplitude elicited by the first pulse of each train (either in the absence or in presence of myricetin) was taken as 100% to better appreciate frequency-dependent block of jpet.aspetjournals.org several basic features with some Ca 2ϩ channel agonists such as Bay K 8644 (Wang et al., 1989; Fusi et al., 2003a) and the structurally related flavonoid quercetin (see below; Saponara et al., 2002) .
Another feature of myricetin action is the frequency-dependent block of I Ca(L) . Frequency-dependent block of I Ca(L) and shift of the channel availability toward more hyperpolarizing potentials are generally observed with drugs possessing a greater affinity for the channel in its inactivated state. In fact, myricetin, like verapamil (McDonald et al., 1994) , inhibited I Ca(L) in a frequency-dependent fashion (use-dependent block); i.e., the repetitive depolarization at a relatively high frequency of stimulation potentiated the inhibition of I Ca(L) . Noticeably, this phenomenon was also observed in the presence of Ba 2ϩ as charge carrier. Therefore, a direct drug effect, rather than a Ca 2ϩ -dependent inactivation of the channel subsequent to current stimulation, seems to be implicated. Furthermore, myricetin, like nicardipine (Bean 1984) , shifted the voltage dependence of the inactivation curve to more negative potentials. Together, these observations indicate that myricetin stabilizes L-type Ca 2ϩ channels in their inactivated state (Bean, 1984) in a voltage-dependent manner. Moreover, its apparent dissociation constant for the inactivated channel (K I ) was about 5 times lower than that for the closed channel (K R ), thus providing an explanation for the shift of the concentration-response curve for I Ca(L) stimulation, recorded at two different V h , toward higher drug concentrations. In fact, there was a significant shift of the curve to the right at V h of Ϫ90 mV, i.e., at a greater membrane hyperpolarization, where a smaller number of channels are supposed to be in the inactivated state. Interestingly, the effects of myricetin on both I Ca(L) kinetics (activation and inactivation) and the slope of steady-state inactivation curve were also affected by V h , being less pronounced when cell membrane potential was held at Ϫ90 mV compared with Ϫ50 mV. The reduced drug sensitivity at V h of Ϫ90 mV further supports the hypothesis of a higher affinity of myricetin for the channel in the inactivated state.
Several studies demonstrate how, under certain conditions, drugs affecting L-type Ca 2ϩ channels (e.g., dihydropyridines, phenylalkylamines, and benzothiazepines) can have opposite effects on I Ca(L) , i.e., inhibition if activators and activation if blockers (McDonald et al., 1994) . Some conditions promote the block of L-type Ca 2ϩ channels by dihydropyridine agonists such as Bay K 8644, in particular, high drug concentrations, depolarized V h , and high pulsing rates. Although the first of these conditions could not be evaluated in the present study because of solubility limits of myricetin, the latter two applied well to the flavonoid. In fact, pulsing rates higher than 1 Hz converted the agonist myricetin into a blocking agent, whereas depolarized V h favored the progressive accumulation of this block when the interstimulus interval was short. Under these experimental conditions, the blocking activity of the L-type Ca 2ϩ channel agonist myricetin clearly emerged.
It might be argued that myricetin effects on I Ca(L) are not due only to its action on L-type Ca 2ϩ channels, but rather the consequence of the recruitment of a third type of Ca 2ϩ channel, i.e., N-type Ca 2ϩ channel. However, the observed, complete block of the current induced by the three well known L-type Ca 2ϩ channel blockers nifedipine, diltiazem, and verapamil in cells exposed to myricetin did not substantiate this hypothesis. Previous studies have shown how quercetin stimulates I Ca(L) in cells isolated from rat tail artery , in clonal rat pituitary GH 4 C 1 (Summanen et al., 2001) , as well as GH 3 cells, but not in neuronal NG108 -15 cells (Wu et al., 2003) . The electrophysiological characteristics of myricetin Ca 2ϩ channel agonism described here (degree of current enhancement, time for maximal effect development, stimulation of current-voltage relationship, stabilization of the inactivated state, lack of effects on I Ca(T) , modulation of voltage dependence, and kinetics of the current) are similar to those already observed with quercetin in the same experimental model . Myricetin stimulation of I Ca(L) , however, only partially reverted upon washout of the drug at V h of Ϫ50 mV, at variance with the effect on current kinetics; moreover, myricetin enhancement of I Ca(L) at V h of Ϫ90 mV, as well as that of I Ba(L) in the same preparation (Fusi et al., 2003a) , were fully reversible. It can be hypothesized that a Ca 2ϩ ion occupies a high-affinity Ca 2ϩ binding site, thus stabilizing the putative myricetin binding site, as is the case with dihydropyridine Ca 2ϩ antagonists (Mitterdorfer et al., 1998) . This would take place in the inactivated state of the channel, where a single Ca 2ϩ ion is tightly coordinated at the selectivity filter, and the putative myricetin binding domain would assume a high-affinity binding conformation for the drug, thus allowing the formation of a ternary complex. This complex is assumed to stabilize the channel in its inactivated state. Therefore, the replacement of Ca 2ϩ with Ba 2ϩ as a charge carrier, as well as the decrease in proportion of inactivated channels at more hyperpolarized V h , should turn the putative myricetin binding domain into a low-affinity binding conformation, thus allowing the complete washout of the drug and the ensuing full reversion of its effects. Of course, this model does not apply to the effects of myricetin on current kinetics that turned to control values even in the presence of Ca 2ϩ at V h of Ϫ50 mV, once more supporting the hypothesis that the flavonoid interacts with distinct sites of the channel protein.
In conclusion, the present electrophysiological data point to myricetin as a vascular L-type Ca 2ϩ channel agonist characterized by a greater affinity for the channel in the inactivated state. Thus, quercetin and myricetin appear as members of a new class of L-type Ca 2ϩ channel modulators of natural source.
